• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,470.11 -238.41
( -0.31%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

CRISIL places Anupam Rasayan's credit ratings on watch
Jun 03,2026
Anupam Rasayan India (ARIL) has received credit ratings for bank facilities (Rs 1620 crore) and non-convertible debentures (Rs 160 crore) at CRISIL A+/ CRISIL A1. These ratings are placed on 'Rating Watch with Developing Implications'.

The ratings have been placed on watch following announcement by ARIL of acquisition of 43.3-48.2% equity stake in Bliss GVS Pharma, a pharmaceutical (pharma) formulations company based in India, which may be funded through debt, equity or internal accrual.